Orthopedic Implants Market

The global orthopedic implants market is projected to grow USD 26.47 billion in 2029 from USD 20.94 billion in 2024, at a CAGR of 4.8% from 2024 to 2029. Technology improvements, rising opportunities in developing markets, increase in prevalence of orthopedic disorders, and the increasing old-age population are contributing factors to the growth of orthopedic implant market. Orthopedic disorders such osteoarthritis, osteoporosis, and fractures are more likely to occur in geriatric people. The need for orthopedic implants to improve mobility and quality of life with these problems has increased as a result of the demographic transition. Along with the market's steady growth, there has been a rise in the number of orthopedic procedures and awareness related to the benefits of orthopedic surgeries.

The orthopedic implants market is consolidated. As of 2023, the key players operating in the global orthopedic implants market are Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), Johnson & Johnson MedTech (US), Smith+Nephew (UK), B.Braun (Germany). In 2023, Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), Johnson & Johnson MedTech (US) held a major share of the orthopedic implants market. These players have adopted key strategies such as acquisitions, partnerships, and expansions in the last four to five years.

To know about the assumptions considered for the study download the pdf brochure

Stryker Corporation (US)

Stryker Corporation is among the leading companies in the global the company has a strong presence in North America, Europe, the Middle East, Africa, and the Asia Pacific, with its brand presence in more than 75 countries across the globe market. The company has a strong presence in North America, Europe, the Middle East, Africa, and the Asia Pacific, with its brand presence in more than 75 countries across the globe. The company offers orthopedic implants through other Orthopedics & Spine division segment. The company focuses on enhancing its product portfolio and continuous innovation and developing new products to sustain its leading position in the market.

Zimmer Biomet Holdings, Inc. (US)

Zimmer Biomet is a medical device company that develops, manufactures, and markets a wide range of healthcare products. The company offers orthopedic implants through its Knees, Hips, and S.E.T segments. The company has a strong geographic presence across countries such as France, Germany, Italy, Spain, the UK, Switzerland, Japan, Australia, New Zealand, South Korea, China, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. Also, the company has a wide distribution network across Benelux, Nordic, Central & Eastern Europe, and the Middle East & Africa. Zimmer Biomet has a strong brand value among orthopedic implants end users, strong R&D capabilities, and a robust product portfolio.

Johnson & Johnson MedTech (US)

Johnson & Johnson MedTech is another major player operating in the orthopedic implants market. The company is engaged in the R&D, manufacturing, and marketing of orthopedic implants and other healthcare products across the globe. It offers orthopedic implants under the MedTech business segment. The company is dedicated to research & innovation to forge and unveil novel offerings that optimize patient results.  The company collaborated with Crossroads Extremity Systems (US) to improve orthopedic care and MedTech devices using new ideas, hoping to give patients better health results. The company holds a significant market share in over 60 nations across diverse territories such as North America, Asia Pacific, Europe, and Africa.

Related Reports:

Orthopedic Implants Market by Product (Knee, Hip, Elbow, Ankle, Shoulder, Foot, Wrist), Material (Metals: Stainless Steel, Titanium Alloy, Cobalt Chromium, Nitinol; Polymers, Ceramics, Hybrid), End user (Hospitals, ASCs, Trauma) - Global Forecast to 2029

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]